Bristol-Myers Squibb
BMY
#176
Rank
HK$990.42 B
Marketcap
HK$484.53
Share price
-1.66%
Change (1 day)
31.90%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): HK$35.41

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is HK$35.46. In 2025 the company made an earnings per share (EPS) of HK$27.15 an increase over its 2024 EPS that were of -HK$34.68.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$35.4130.46%
2025HK$27.15-178.28%
2024-HK$34.68-213.92%
2023HK$30.4430.2%
2022HK$23.38-6.04%
2021HK$24.88-179.29%
2020-HK$31.38-281.37%
2019HK$17.30-27.21%
2018HK$23.77
2016HK$20.95175.26%
2015HK$7.61-19.83%
2014HK$9.49-22.44%
2013HK$12.2434.48%
2012HK$9.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.41 47.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$41.19 16.15%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.57-84.29%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$45.91 29.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$242.35 583.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$136.35 284.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$15.54-56.18%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$18.52-47.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$7.79-78.03%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$55.86 57.52%๐Ÿ‡ฌ๐Ÿ‡ง UK